Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313454612> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- W4313454612 endingPage "426" @default.
- W4313454612 startingPage "414" @default.
- W4313454612 abstract "Niclosamide, a STAT3 inhibitor, is widely under investigation due to its anti-cancer properties. STAT3 also exhibits an exciting role in the immune responses.This study aimed to evaluate the impact of niclosamide on immune response of mice.Niclosamide was administered to balb/c mice. To evaluate cell-mediated immune response, a contact-hypersensitivity (CHS) test, cyclophosphamide-induced neutropenic assay, and carbon clearance test were performed, whereas a humoral immune response was evaluated by hemagglutination assay (HA) and mice lethality test. The concentration of TGF-β1 was determined by enzyme-linked immunosorbent assay (ELISA) on murine peritoneal macrophages.In the CHS test, niclosamide caused a decrease in skin thickness, significantly exhibiting a decrease in inflammation. A highly significant decrease in overall leukocyte count (lymphocytes and neutrophils) was observed before and after cyclophosphamide injection as compared with the control group. However, only a highly significant decrease in the neutrophil percentage was observed. Niclosamide has decreased the phagocytic process immensely compared with the control. In the HA titer, niclosamide was found to reduce the antibodies' titer compared with the negative control group. In the mice lethality test, the treatment groups have shown an increase in the percentage of mortality. TGF-β1 elevated in peritoneal macrophages when treated with niclosamide, in a dose-dependent manner.Niclosamide exerts potent immunomodulatory effects by significantly suppressing cell-mediated and humoral immune responses and increasing the levels of TGF-β1 in mice. Niclosamide might be added as an adjuvant to immunosuppressive drugs for the treatment of autoimmune diseases." @default.
- W4313454612 created "2023-01-06" @default.
- W4313454612 creator A5012090945 @default.
- W4313454612 creator A5012516138 @default.
- W4313454612 creator A5054014554 @default.
- W4313454612 creator A5069045632 @default.
- W4313454612 creator A5070035363 @default.
- W4313454612 creator A5071826221 @default.
- W4313454612 date "2022-12-01" @default.
- W4313454612 modified "2023-09-29" @default.
- W4313454612 title "Niclosamide Modulates the Cellular and Humoral Immune Response in Balb/c Mice." @default.
- W4313454612 doi "https://doi.org/10.22034/iji.2022.90653.2022" @default.
- W4313454612 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36585883" @default.
- W4313454612 hasPublicationYear "2022" @default.
- W4313454612 type Work @default.
- W4313454612 citedByCount "0" @default.
- W4313454612 crossrefType "journal-article" @default.
- W4313454612 hasAuthorship W4313454612A5012090945 @default.
- W4313454612 hasAuthorship W4313454612A5012516138 @default.
- W4313454612 hasAuthorship W4313454612A5054014554 @default.
- W4313454612 hasAuthorship W4313454612A5069045632 @default.
- W4313454612 hasAuthorship W4313454612A5070035363 @default.
- W4313454612 hasAuthorship W4313454612A5071826221 @default.
- W4313454612 hasConcept C126322002 @default.
- W4313454612 hasConcept C159654299 @default.
- W4313454612 hasConcept C185592680 @default.
- W4313454612 hasConcept C18903297 @default.
- W4313454612 hasConcept C203014093 @default.
- W4313454612 hasConcept C2776306103 @default.
- W4313454612 hasConcept C2776694085 @default.
- W4313454612 hasConcept C2776755627 @default.
- W4313454612 hasConcept C2911179620 @default.
- W4313454612 hasConcept C71924100 @default.
- W4313454612 hasConcept C86803240 @default.
- W4313454612 hasConcept C8891405 @default.
- W4313454612 hasConcept C98274493 @default.
- W4313454612 hasConceptScore W4313454612C126322002 @default.
- W4313454612 hasConceptScore W4313454612C159654299 @default.
- W4313454612 hasConceptScore W4313454612C185592680 @default.
- W4313454612 hasConceptScore W4313454612C18903297 @default.
- W4313454612 hasConceptScore W4313454612C203014093 @default.
- W4313454612 hasConceptScore W4313454612C2776306103 @default.
- W4313454612 hasConceptScore W4313454612C2776694085 @default.
- W4313454612 hasConceptScore W4313454612C2776755627 @default.
- W4313454612 hasConceptScore W4313454612C2911179620 @default.
- W4313454612 hasConceptScore W4313454612C71924100 @default.
- W4313454612 hasConceptScore W4313454612C86803240 @default.
- W4313454612 hasConceptScore W4313454612C8891405 @default.
- W4313454612 hasConceptScore W4313454612C98274493 @default.
- W4313454612 hasIssue "4" @default.
- W4313454612 hasLocation W43134546121 @default.
- W4313454612 hasOpenAccess W4313454612 @default.
- W4313454612 hasPrimaryLocation W43134546121 @default.
- W4313454612 hasRelatedWork W1572283981 @default.
- W4313454612 hasRelatedWork W2360493200 @default.
- W4313454612 hasRelatedWork W2399476554 @default.
- W4313454612 hasRelatedWork W2411114470 @default.
- W4313454612 hasRelatedWork W2748952813 @default.
- W4313454612 hasRelatedWork W2899084033 @default.
- W4313454612 hasRelatedWork W3048051248 @default.
- W4313454612 hasRelatedWork W4200563690 @default.
- W4313454612 hasRelatedWork W4249342726 @default.
- W4313454612 hasRelatedWork W2327397534 @default.
- W4313454612 hasVolume "19" @default.
- W4313454612 isParatext "false" @default.
- W4313454612 isRetracted "false" @default.
- W4313454612 workType "article" @default.